RANI vs. HOWL
Compare and contrast key facts about Rani Therapeutics Holdings, Inc. (RANI) and Werewolf Therapeutics, Inc. (HOWL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RANI or HOWL.
Correlation
The correlation between RANI and HOWL is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RANI vs. HOWL - Performance Comparison
Key characteristics
RANI:
-0.43
HOWL:
-0.80
RANI:
-0.09
HOWL:
-1.71
RANI:
0.99
HOWL:
0.81
RANI:
-0.51
HOWL:
-0.86
RANI:
-0.83
HOWL:
-1.25
RANI:
59.40%
HOWL:
63.78%
RANI:
115.06%
HOWL:
99.65%
RANI:
-96.43%
HOWL:
-93.45%
RANI:
-95.06%
HOWL:
-93.21%
Fundamentals
RANI:
$101.29M
HOWL:
$62.39M
RANI:
-$1.05
HOWL:
-$1.52
RANI:
$0.00
HOWL:
$1.89M
RANI:
-$503.00K
HOWL:
$967.00K
RANI:
-$36.19M
HOWL:
-$47.05M
Returns By Period
In the year-to-date period, RANI achieves a 26.28% return, which is significantly higher than HOWL's -6.76% return.
RANI
26.28%
22.70%
-43.65%
-47.09%
N/A
N/A
HOWL
-6.76%
1.47%
-37.27%
-79.15%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RANI vs. HOWL — Risk-Adjusted Performance Rank
RANI
HOWL
RANI vs. HOWL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Rani Therapeutics Holdings, Inc. (RANI) and Werewolf Therapeutics, Inc. (HOWL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RANI vs. HOWL - Dividend Comparison
Neither RANI nor HOWL has paid dividends to shareholders.
Drawdowns
RANI vs. HOWL - Drawdown Comparison
The maximum RANI drawdown since its inception was -96.43%, roughly equal to the maximum HOWL drawdown of -93.45%. Use the drawdown chart below to compare losses from any high point for RANI and HOWL. For additional features, visit the drawdowns tool.
Volatility
RANI vs. HOWL - Volatility Comparison
Rani Therapeutics Holdings, Inc. (RANI) has a higher volatility of 29.06% compared to Werewolf Therapeutics, Inc. (HOWL) at 17.47%. This indicates that RANI's price experiences larger fluctuations and is considered to be riskier than HOWL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RANI vs. HOWL - Financials Comparison
This section allows you to compare key financial metrics between Rani Therapeutics Holdings, Inc. and Werewolf Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities